Published on
Apr 14, 2025
Beyond the Breakthrough: Industry Leaders Address Key Hurdles Facing Cell and Gene Therapies
FDA approval for chimeric antigen receptor (CAR) T cell therapy occurred 30 years after the initial research began. Prior to the approval, the first successful treatment using CAR T cells was in 2010 for a retired Marine with chronic leukemia. Two years …
Source:
BioSpace
-
Pending
